Improving Breast Health Knowledge Among Women Using a Gamified Metaverse-Based Platform

Not Applicable

Completed

• Conditions: Health Education; Breast Neoplasms

• Registration Number: NCT06930898
• Lead Sponsor: University of Malaya

Brief Summary

This randomized controlled trial aimed to evaluate the effectiveness of Mammoverse, a gamified metaverse-based educational platform, in improving breast health knowledge among women in China. Participants were randomly assigned to either a gamified or non-gamified version of the platform. Both groups received identical educational content, but only the gamified group experienced interactive game elements such as avatars, progress feedback, and rewards. Knowledge was assessed at baseline, immediately post-intervention, and at 4-week follow-up. The study found that the gamified platform significantly improved knowledge retention and participant engagement compared to the non-gamified version.

This ClinicalTrials.gov registration reflects only the randomized controlled trial (RCT) portion of a broader mixed-methods study that was approved by the University of Malaya Research Ethics Committee (Ref: UM.TNC2/UMREC_3967). The full study protocol includes three methodological approaches, and this registration pertains specifically to the RCT component involving the Mammoverse platform. Other study components are not included in this registration.

Detailed Description

Mammoverse is a 3D metaverse environment designed to promote breast health knowledge through immersive and interactive learning. The gamified version included user avatars, badges, tasks, and personalized feedback to increase motivation and engagement. The study recruited 72 women aged 18 and above, and used a pre-post-follow-up design. Outcome measures were based on an adapted 18-item Breast Health Literacy Questionnaire. The trial was conducted entirely online, with ethics approval from the University of Malaya Research Ethics Committee.

Study Timeline

• Study Start: 2024-12-01
• Primary Completion: 2025-02-01
• Study Completion: 2025-03-24
• Status Verified: 2025-04
• Study First Submitted: 2025-04-08
• Study First Submitted QC: 2025-04-08
• Last Update Submitted: 2025-04-15
• Study First Posted: 2025-04-16
• Last Update Posted: 2025-04-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 72

Inclusion Criteria

• Female participants aged 18 years and above
• Able to read and understand Chinese
• Access to a digital device and stable internet connection
• Willing to provide informed consent

Exclusion Criteria

• Cognitive impairment or mental health condition that affects participation
• Inability to complete the full intervention and follow-up sessions
• Incomplete baseline assessment

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change in Breast Health Knowledge Score from Baseline to 4 Weeks Post-Intervention	Baseline and 4 weeks post-intervention	Assessed using an 18-item adapted Breast Health Literacy Questionnaire. Scores range from 0 to 18, with higher scores indicating greater knowledge. Main comparison is between baseline and 4-week follow-up.

Secondary Outcome Measures

Name	Time	Method
Change in Breast Health Knowledge Score from Baseline to Immediately Post-Intervention	Baseline and immediately post-intervention	Same questionnaire used to assess immediate knowledge gain after the intervention.

Trial Locations

Locations (2)

Online Recruitment - Hangzhou, Zhejiang, China; 🇨🇳 Hangzhou, Zhejiang, China

University of Malaya; 🇲🇾 Kuala Lumpur, Malaysia